Katinko
Katinko, licence 80072030: active licence in Health Canada data. The French and European references below do not constitute authorisation for sale in France or an assessment of safety or efficacy.
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
Natural health product licensed in Canada
- Licence holder
- Greenstone Pharmaceutical H.K., Inc.
- NPN or DIN-HM
- 80072030
- Status
- Active licence
- Licence date
- 16 August 2016
- Revision date
- 15 September 2016
- Form
- Onguent
- Route of administration
- Topique
- Application type
- Officinale
If this product were sold in France
No point flagged by the rules we apply.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| 2-hydroxybenzoate de méthyle | 8.0 % | Not calculated |
| l-Menthol | 7.5 % | Not calculated |
| dl-Camphre | 2.6 % | Not calculated |
| 2-hydroxybenzoate de méthyle | 8.0 milligramme | Not calculated |
| l-Menthol | 7.5 milligramme | Not calculated |
| dl-Camphre | 2.6 milligramme | Not calculated |
Non-medicinal ingredients
Vaseline blanche
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes, adolescents et enfants | minimum: 2.0 Année(s) | Not specified | minimum: 3.0 Tous les jours ; maximum: 4.0 Tous les jours |
Uses authorised in Canada
Temporarily relieves aches and pains of muscles and joints associated with one or more of the following: Simple backache, lumbago, strains and sprains (involving muscles, tendons, and/or ligaments), and arthritis.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
- Effets indésirables connus
Rashes and/or burning discomfort have been known to occur; in which case, discontinue use. Hypersensitivity has been known to occur; in which case, discontinue use.
- Précautions et mises en garde
Keep out of the reach of children. If overdose or accidental ingestion occurs, call a Poison Control Center immediately. If symptoms persist and/or worsen after 7 days or re-occur within a few days, discontinue use and consult a health care practitioner. If you are pregnant or breastfeeding, consult a healthcare practitioner prior to use. If you are taking anticoagulant medications, consult a health care practitioner prior to use.
Source
Official Health Canada record, licence 80072030
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
List in the official revision dated (register: Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks).
List recorded in 2016. Photograph the packaging to check whether it has changed.
Has the product changed? Photograph the packaging.